Dr. Rugo on Guidelines for the Treatment of Metastatic Breast Cancer

ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives ...Подробнее

Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 StudyПодробнее

HER2 In Breast Cancer: Testing Guidelines and New Treatment ApproachesПодробнее

Hope Rugo, MD, considers chemotherapy recommendations based on findings from KEYNOTE-355Подробнее

Dr. Rugo on the Advances in the Treatment of HER2-Positive Breast CancerПодробнее

Dr. Rugo on Chemotherapy for Metastatic Breast CancerПодробнее

Hope Rugo, MD: Advances and Challenges In the Treatment of Metastatic Breast CancerПодробнее

Dr. Don Dizon on Living With Metastatic Breast Cancer from MBCN's 2013 Conference in HoustonПодробнее

Dr. Rugo Discusses Guidelines for Metastatic Breast Cancer ManagementПодробнее